Deletion of 7q31.1 supports involvement of FOXP2 in language impairment : Clinical report and reviewLENNON, P. A; COOPER, M. L; PEIFFER, D. A et al.American journal of medical genetics. Part A. 2007, Vol 143, Num 8, pp 791-798, issn 1552-4825, 8 p.Article

Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate. Authors' repliesABRAHAM, E. H; OKUNIEFF, P; HAWS, C et al.Science (Washington, D.C.). 1997, Vol 275, Num 5304, pp 1324-1326, issn 0036-8075Article

Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gatingGUNDERSON, K. L; KOPITO, R. R.The Journal of biological chemistry (Print). 1994, Vol 269, Num 30, pp 19349-19353, issn 0021-9258Article

Identification of critical regions for clinical features of distal 10q deletion syndromeYATSENKO, S. A; KRUER, M. C; GUNDERSON, K. L et al.Clinical genetics. 2009, Vol 76, Num 1, pp 54-62, issn 0009-9163, 9 p.Article

Characterization of de novo microdeletions involving 17q11.2q12 identified through chromosomal comparative genomic hybridizationBRUNETTI-PIERRI, N; GRANGE, D. K; CRAIGEN, W. J et al.Clinical genetics. 2007, Vol 72, Num 5, pp 411-419, issn 0009-9163, 9 p.Article

Failure of the cystic fibrosis transmembrane conductance regulator to conduct ATPREDDY, M. M; QUINTON, P. M; HAWS, C et al.Science (Washington, D.C.). 1996, Vol 271, Num 5257, pp 1876-1879, issn 0036-8075Article